CRV
Listed as “Axiom”
- First observed:
- 31 Oct 2026
- Investment announced:
- Date not recorded
Axiom
Company website description: Axiom provides frontier intelligence for human drug toxicity, helping scientists reduce unexpected toxicity earlier and develop safer medicines with less animal testing.
- Tracked VC backers
- 1
Publicly documented VC backing
These sources establish that the firm lists the company. The observation date records when RiseFinder captured the relationship; it does not establish when the investment happened.
Dated public activity
No dated funding or investment events are recorded yet. Initial portfolio listings establish the starting baseline and earn no points.